
Ratings & Reviews
Enjoy a $10 Gift Card for each $60 spent! CODE: DAD | SHOP NOW
Buy Online before 3PM, get it today with Buy Online, Pick-up in Store. Shop now
Click HERE for information on the COVID-19 tests offered free of charge.
Access to medications for prevention and treatment of COVID-19 in pharmacy: click here to learn more
$10 Gift Card for each $60 spent CODE: DAD | SHOP NOW
Buy Online before 3PM, get it today with Buy Online, Pick-up in Store. Shop now
Click HERE for information on the COVID-19 tests offered free of charge.
Access to medications for prevention and treatment of COVID-19 in pharmacy: click here to learn more
Sorry, no matches for your search on
Here are a few tips to help you find what you are looking for:
Your message has been sent.
Dexyane MeD soothing repairing cream treats, promotes the disappearance of eczema lesions and limits their reappearance. The skin is protected thanks to its bandage texture which forms a semi-occlusive film on the surface. It can be directly applied to inflammatory lesions of eczema.
Relieves inflammation: -73% of pain from 8 days.
Improves the efficacy of dermo-corticosteroids: -83% relapse rate at 15 days.
Faster efficacy from 3 days on moderate to severe lesions.
Open study on 40 adults with chronic hand eczema. Dexyane Med is applied to the lesions twice a day for 22 days.
Description
Dexyane MeD soothing repairing cream treats, promotes the disappearance of eczema lesions and limits their reappearance. The skin is protected thanks to its bandage texture which forms a semi-occlusive film on the surface. It can be directly applied to inflammatory lesions of eczema.
Relieves inflammation: -73% of pain from 8 days.
Improves the efficacy of dermo-corticosteroids: -83% relapse rate at 15 days.
Faster efficacy from 3 days on moderate to severe lesions.
Open study on 40 adults with chronic hand eczema. Dexyane Med is applied to the lesions twice a day for 22 days.
Instructions
Application Tips
Dosage
Warnings
Ingredients
Fragrance Notes
Ratings & Reviews
Loading...